Corneal endothelial damage in phacoemulsification using an anterior chamber maintainer compared with using an ophthalmic viscosurgical device
dc.contributor.author | Mayali H. | |
dc.contributor.author | Baser E.F. | |
dc.contributor.author | Kurt E. | |
dc.contributor.author | Ilker S.S. | |
dc.date.accessioned | 2024-07-22T08:06:03Z | |
dc.date.available | 2024-07-22T08:06:03Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Purpose: To compare the effects of phacoemulsification surgery (PE) using an anterior chamber maintainer (ACM) and conventional PE using an ophthalmic viscosurgical device (OVD) on corneal endothelial cells. Setting: Department of Ophthalmology, Celal Bayar University, Manisa, Turkey. Design: Prospective randomized controlled trial. Methods: Eyes in the OVD group (n = 50) underwent conventional PE, whereas eyes in the ACM group (n = 50) underwent PE using an ACM. Endothelial cell density (ECD), coefficient of variation (CV), hexagonality (HEX), and noncontact central corneal thickness (CCT) measurements were performed by specular microscopy before and at 1 month, 3 months, and 6 months after PE. Results: This study included 100 eyes of 97 patients undergoing PE. The mean age was 64.7 ± 10.6 years in the OVD group, 64.0 ± 12.6 years in the ACM group (P >.05). The groups did not differ significantly in preoperative ECD, CV, HEX, and CCT or total PE time (P >.05 for all). ECD was significantly lower in the ACM group compared with the OVD group at postoperative 1 month, 3 months, and 6 months (P =.002, P =.002, and P =.001, respectively). Similarly, ECD loss compared with preoperative value was greater in the ACM group at all postoperative timepoints (P =.003, P =.001, and P =.001, respectively). CV increased and HEX decreased in both groups postoperatively (P >.05 for both). CCT showed a transient increase of less than 10 m at postoperative 1 month in both groups (P =.296). Conclusions: PE with ACM was associated with greater corneal ECD loss compared with conventional PE. ACM should not be used during PE in patients with limited corneal endothelial reserve. © 2021 Elsevier Inc.. All rights reserved. | |
dc.identifier.DOI-ID | 10.1097/j.jcrs.0000000000000493 | |
dc.identifier.issn | 08863350 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13364 | |
dc.language.iso | English | |
dc.publisher | Lippincott Williams and Wilkins | |
dc.subject | Anterior Chamber | |
dc.subject | Cell Count | |
dc.subject | Endothelial Cells | |
dc.subject | Endothelium, Corneal | |
dc.subject | Humans | |
dc.subject | Lens Implantation, Intraocular | |
dc.subject | Middle Aged | |
dc.subject | Phacoemulsification | |
dc.subject | Prospective Studies | |
dc.subject | bupivacaine | |
dc.subject | cyclopentolate | |
dc.subject | dexamethasone | |
dc.subject | epinephrine | |
dc.subject | gentamicin | |
dc.subject | lidocaine | |
dc.subject | moxifloxacin | |
dc.subject | prednisolone sodium phosphate | |
dc.subject | tropicamide | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | cell density | |
dc.subject | central corneal thickness | |
dc.subject | controlled study | |
dc.subject | cornea endothelium | |
dc.subject | corneal endothelial cell loss | |
dc.subject | endothelium cell | |
dc.subject | female | |
dc.subject | human | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | middle aged | |
dc.subject | phacoemulsification | |
dc.subject | postoperative complication | |
dc.subject | preoperative evaluation | |
dc.subject | prospective study | |
dc.subject | randomized controlled trial | |
dc.subject | senile cataract | |
dc.subject | specular microscopy | |
dc.subject | anterior eye chamber | |
dc.subject | cell count | |
dc.subject | lens implantation | |
dc.title | Corneal endothelial damage in phacoemulsification using an anterior chamber maintainer compared with using an ophthalmic viscosurgical device | |
dc.type | Article |